Adverse reactions identification and documentation

Similar documents
Contents. Standing Orders. Policy

Medicine Reconciliation FREQUENTLY ASKED QUESTIONS NATIONAL MEDICATION SAFETY PROGRAMME

Medicine Management Policy

Policy for the Administration of the First Dose of an Intravenous Antibiotic to Adult and Paediatric Patients by Nurses

1 Ordering and Receipt of Controlled and Recorded Drugs and Controlled Drug Prescription Pads

Unlicensed Medicines Policy Document

Admission Transfer and Discharge Protocol Community Hospitals. 1 Patient Categories and Clinical Criteria for Patient Admission

Chapter 13. Documenting Clinical Activities

Overview of e-portfolio Learning Activities for Part III Community Pharmacy Placements

CLINICAL AUDIT. The Safe and Effective Use of Warfarin

New v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee

APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION

Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02

Reconciliation of Medicines on Admission to Hospital

PHARMACY SERVICES/MEDICATION USE

New To Therapy GuildCare Program

The Medicines Policy. Chapter 3: Standards of Practice ORDERING WARD STOCK AND NON-STOCKS INPATIENT ITEMS

The Medicines Policy. Chapter 6: Standards of Practice. MISCELLANEOUS and DISCHARGE

Medicines New Zealand

MEDICAL COUNCIL OF NEW ZEALAND

Aged residential care (ARC) Medication Chart implementation and training guide (version 1.1)

MEDICAL COUNCIL OF NEW ZEALAND

Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business

This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software.

Section 7: Core clinical headings

Adult Patient Controlled Analgesia (PCA)

All Wales Multidisciplinary Medicines Reconciliation Policy

St. Michael s Hospital Medication Reconciliation Learning Package

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final

Non Medical Prescribing Policy Register No: Status: Public

Clinical. Prescribing Medicines SOP. Document Control Summary. Contents

South Canterbury District Health Board

Authority to Prescribe Medications Policy

Clinical Pharmacist Renal

NEW JERSEY. Downloaded January 2011

Community Health Network of San Francisco Committee on Interdisciplinary Practice

Medicines Management Strategy

1. Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) Decisions Guideline

Improving patient safety and infection. Patient Safety Forum Dr J Coleman 1 ELECTRONIC PRESCRIBING AND CLINICAL DECISION SUPPORT (CDS)

Safe Medicine Administration Policy

Washington State Hospital Association Standardization of Color-Coded Wristbands in Washington Implementation Toolkit

Serious Adverse Event Report 1 July June 2015

Prescribing and Administration of Medication Procedure

PATIENT ASSESSMENT POLICY Page 1 of 7

Clinical Interdepartmental Policy and Procedure

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Policy on Admission of Children To The Acute Children s Wards Within the WHSCT August 2012

Medicines Reconciliation: Standard Operating Procedure

NON-MEDICAL PRESCRIBING POLICY

guide AUGUST 2017 for Pharmacist Salary Banding

Non Medical Prescribing Policy

Petition 2014/45 of Carolyn Hodson and 184 others

MANAGING THE INR CLINIC : IJN EXPERIENCE

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients

Medicines Reconciliation Standard Operating Procedures

Medication Management Policy and Procedures

Standard 1: Governance for Safety and Quality in Health Service Organisations

Derby Hospitals NHS Foundation Trust. Drug Assessment

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS

Options for models for prescribing under a nationally consistent framework

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

High Returns Pharming COWS

Long Term Care Pharmacy

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist

COA ADVANCED PRACTICE PROVIDER CALL

Acute Crisis Units. Shelly Rhodes, Provider Relations Manager

The Introduction of Automated Medication Management and Dispensing System with Omnicell

February New Zealand Health and Disability Services National Reportable Events Policy 2012

Section 6: Referral record headings

Section Title. Prescribing competency framework Catherine Picton, Lead author

Manis Aged Care Limited

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

Practice Tools for Safe Drug Therapy

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

Self-assessment worksheet for the Professional Practice Standards version 4

Ensuring Safe & Efficient Communication of Medication Prescriptions

WHO Programme for International Drug Monitoring, Pharmacovigilance Centres & Patient Safety

Admission Record IVF/Gynae

Patients Own Medications Policy

Clinical Check of Prescriptions in Ward Areas

Transfer of Patients between Hospitals

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

Mandatory Competency Assessment for Medicines Management (Not Injectable Medicines) for Registered Practitioners IN HOSPITAL

PATIENT GROUP DIRECTION (PGD) FOR THE

Medicines Reconciliation Policy

Table of Contents Service Information... 2

Block Title: Patient Care Experience Block #: PHRM 701, 702, 703, 704 and PHRM 705, 706, and 707 (if patient care)

Dr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure

Post-Test/ Evaluation

Infusion Therapy Learning Exercise: Infusion Documentation

Constant Pursuit of Medication Safety. Geraldine Koh Chief Pharmacist

Taranaki District Health Board

Central Venous Access Devices (CVADs)

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

New Zealand electronic Prescription Service

Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that

POLICY ON NURSE PRESCRIBING IN OLCHC EDITION 6

Transcription:

Adverse reactions identification and documentation Contents Policy... 1 Purpose... 2 Scope... 2 Associated documents... 2 Responsibilities on admission for capture and documentation... 3 Admission Staff (Ward Clerks and/or Nursing Staff)... 3 Clinical Staff (Doctors, Pharmacists and/or Nursing Staff)... 3 Clinical staff responsibilities prior to any drug/fluid... 4 Administration... 4 Adverse reaction occurring while inpatients... 4 Clinical staff reporting and documentation... 4 Particular medical staff responsibilities... 4 Referral requirements... 5 Particular pharmacist responsibilities... 5 Responsibilities on Discharge... 6 Medical Staff... 6 Pharmacist... 6 Clinical Record Department Staff... 6 References... 6 Policy All adverse reactions to medicines (including contrast media), vaccines, therapeutic devices (including latex and wound dressings), complementary therapies and foods will be identified and documented. Please note: Refer to the CDHB Food Allergies Policy regarding policy requirements for food related reactions (currently in development) All reactions to therapeutic devices i.e. latex, dressings, solutions need to be documented within the patients current clinical notes and care plan. Page 1 of 6 Be reviewed by: August 2016

Purpose To minimise harm by preventing exposure to, or the Re-administration of, a harmful substance. To minimise situations where therapy is withheld unnecessarily. To contribute to post-marketing surveillance and drug safety. Scope All relevant administration staff (including ward clerks and clinical record staff) or designated clinical staff are responsible to ensure timely retrieval of adverse reaction documentation. All relevant clinical staff including prescribers, nurses, midwives and pharmacists are responsible to ensure identification and accurate documentation of: Adverse reactions previously documented and/or reported by the patient. Suspected adverse reactions associated with this hospital admission. Associated documents Canterbury DHB Volume 2 - Legal and Quality - Incident Management Policy Canterbury DHB Volume 11 - Clinical - Clinical Record Requirements Canterbury DHB Volume 12 - Fluid and Medication Management Blood and Blood Products Policy - Acute Transfusion Reactions Drug Treatment Sheet (QMR0004) Adult National Medication Chart (NATAMC) or patient drug chart Preferred Medicines List (PML) (The Pink Book) -Assessing Adverse Reactions Adverse Drug Reaction (ADR) form (QMR0128) Adverse Reaction Sticker (QL00250) Incident Report Form (Ref. 1077) Management Guidelines for Common Medical Conditions (The Blue Book) Admission, Discharges, Transfers (ADT) IS Manual for Users of Homer, CareSys or Healthlink patient management systems MedicAlert Application for Membership Page 2 of 6 Be reviewed by: August 2016

Responsibilities on admission for capture and documentation Admission Staff (Ward Clerks and/or Nursing Staff) Check the patient management system (Homer, CareSys or Healthlink) and Health Connect South (HCS) for previously documented adverse reactions - Print the page if any reactions are documented. Place the adverse reaction printouts in the front of the clinical notes (behind the green admission sheet) for clinical staff. Place a completed orange sticker on the front of the current clinical notes cover Clinical Staff (Doctors, Pharmacists and/or Nursing Staff) Review electronic information from the patient management system, the clinical notes, referral letters and patient's (or whanau's) response regarding previous adverse reactions. Clinical staff must document (include date and sign) within the patient's current clinical notes whether the patient has A previous reaction to a medicine, vaccine, therapeutic device, complementary therapy or food (food can potentially impact on medication prescribing). Include substance (preferably using generic name), reaction and date (where known). OR No known previous reaction to any substance. Clinical staff must document the substance and reaction on the orange adverse reaction sticker and place this on the patient's medication chart and/or fluid prescription chart OR Document the substance and reaction on the National Medication Chart OR Tick the 'no' boxes on the patient medication chart or National Adult Medication Chart Page 3 of 6 Be reviewed by: August 2016

Clinical staff responsibilities prior to any drug/fluid Administration Clinical staff involved in the administration of any medicine, vaccine or therapeutic device will check with the patient (or whanau) that they have no known previous reactions to the medicine, vaccine or therapeutic device prior to each administration Adverse reaction occurring while inpatients Clinical staff reporting and documentation If an adverse reaction occurs: Assess the clinical situation and act accordingly Medical staff are required to assess the patient as soon as possible post reaction A clinical staff member must update or add the Adverse Reaction Sticker (QL00250) on the patient s medication chart and front cover of current clinical notes(eg.qmr0004) or write on the appropriate boxes on the National Adult Medication Chart, date and sign Record adverse reaction details (substance and reaction) in the clinical record. Where possible use generic names. For reactions to foods or other substances refer to the CDHB Food Allergy Management Policy Vol 11 For all severe reactions, inform a hospital pharmacist at first available opportunity. If appropriate, ensure an Incident Report Form is completed. Particular medical staff responsibilities Assess the adverse reaction refer to the PML for guidance. For serious reactions where the patient should avoid this product in the future, complete and sign an adverse reaction form (QMR0128) and leave the form in the front of the medical notes. Alternatively, complete the form on the Intranet (Clinical Info > Clinical Pharmacology > ADR reporting > complete form and print a copy to be filed in the patient s notes). OR If your assessment determines that an adverse reaction is unlikely, cross out the adverse reaction information on the Page 4 of 6 Be reviewed by: August 2016

patient s medication chart sign, write your name and date this clearly. Ensure this information is also documented in the clinical notes to avoid confusion. Discuss the benefits of Medic Alert with the patient if this is a serious reaction. Forms are available from the Pharmacy Department. Referral requirements For adverse reactions involving anaesthetics, refer to the Department of Anaesthesia, Christchurch Hospital, for review. For severe reactions that are possibly anaphylactic or anaphylactoid, refer to the Department of Rheumatology/Immunology, Christchurch Hospital. Particular pharmacist responsibilities If the adverse reaction has been assessed by the medical staff to be serious and the patient should avoid this medicine in the future: Ensure an adverse reaction form (QMR0128) is completed and filed as follows: Top copy Centre for Adverse Reaction Monitoring (CARM) PO Box 913, Dunedin. Second copy patient clinical notes (in the front with other enduring information) Third copy the Pharmacy Department of a CDHB hospital. A designated adverse reaction pharmacist for all Canterbury DHB hospitals will: Add serious/severe adverse reactions to the hospital s patient management system (e.g. Homer, CareSys or Healthlink). Check the Clinical Pharmacology Home Site for electronically reported adverse reactions at least monthly and: Send a copy to the appropriate hospital Pharmacy Department for filing. Send a copy to the appropriate clinical record department for filing. Send a copy to CARM. A designated pharmacist at each hospital will: Maintain a file of adverse reaction reports for their hospital. Add adverse reaction information, as received, to the epharmacy dispensing system. Page 5 of 6 Be reviewed by: August 2016

Advise the Canterbury DHB adverse reaction pharmacist of serious/severe adverse reactions to be added to the hospital s patient management system. Responsibilities on Discharge Medical Staff Must communicate suspected adverse reactions to the patient s General Practitioner and patient wishes regarding Medic Alert bracelet in the discharge summary. Must communicate suspected adverse reactions in transfer letters/ documentation to other hospitals and rest homes. Pharmacist If a yellow card (medicine list) is provided on discharge, ensure the patient s adverse reactions are documented on this card. Clinical Record Department Staff Ensure adverse reaction forms (QMR0128) and letters from CARM regarding specific patients, are filed at the front of the clinical record with other enduring documents. References The HDC Code of Health and Disability Services Consumers' Rights Regulation 1996 New Zealand Standard: Health Records (NZS 8153:2002) Key Health Information Requirements Policy Owner Policy Authoriser Medicines Advisory Committee CMO & EDON Date of Authorisation August 2014 Page 6 of 6 Be reviewed by: August 2016